Form 4: Clorox Director Pierre Breber Increases Equity Stake Through Deferred Stock Units

Clorox Company Director Pierre R. Breber acquired additional Deferred Stock Units through dividend reinvestment and in lieu of quarterly fees, significantly increasing his beneficial ownership.

Summary

• Pierre R. Breber, a Director of The Clorox Company (CLX), acquired additional Deferred Stock Units (DSUs) in two separate transactions.
• On May 9, 2025, 2.2874 DSUs were acquired through dividend reinvestment, consistent with the Independent Directors' Deferred Compensation Plan.
• On June 30, 2025, an additional 242.0749 DSUs were received by Breber in lieu of quarterly director's fees.
• Each DSU converts on a 1-for-1 basis into Clorox Common Stock.
• The DSUs are scheduled to be settled entirely in Clorox stock upon Breber's retirement or other termination of service as a Director.
• Following these reported transactions, Breber's total beneficial ownership of DSUs increased to 497.0258 units.

Sentiment

Score: 6

Explanation: Slightly positive as it indicates continued director alignment with shareholder interests through equity compensation, which is a standard and generally favorable practice.

Positives

• Director Pierre R. Breber increased his beneficial ownership of Clorox stock equivalents, further aligning his financial interests with those of long-term shareholders.
• The acquisition of Deferred Stock Units through dividend reinvestment and in lieu of cash fees demonstrates a commitment to long-term investment in the company's equity.
• The Independent Directors' Deferred Compensation Plan facilitates equity-based compensation for directors, fostering long-term alignment with company performance.

Future Outlook

The Deferred Stock Units will be settled 100% in Clorox common stock in connection with the reporting person's retirement or other termination of service as a Director, indicating a long-term equity holding strategy.

Industry Context

This transaction is a routine insider compensation disclosure common across publicly traded companies, where directors often receive equity-based compensation to align their interests with long-term shareholder value. It does not reflect broader industry trends or competitive shifts.

Comparison to Industry Standards

• The practice of compensating directors with deferred stock units is a standard corporate governance practice across many industries, including consumer goods. This aligns director incentives with long-term company performance and shareholder returns.
• This approach is similar to compensation structures observed at peer companies such as Procter & Gamble (PG) or Kimberly-Clark (KMB), which also utilize equity-based compensation for their board members to foster long-term alignment.

Corporate Governance

Stakeholder Impact

• Shareholders: Increased alignment of a director's financial interests with long-term shareholder value.
• Director (Pierre R. Breber): Receives equity-based compensation, deferring cash income into future stock ownership.

Next Steps

• Settlement of Deferred Stock Units into Clorox common stock upon Pierre R. Breber's retirement or termination of service as a Director.

Key Dates

Recommendation

Keywords

Clorox, CLX, Form 4, Insider Transaction, Deferred Stock Units, Director Compensation, Equity Compensation, Share Ownership, Corporate Governance